Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.
about
Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data.Hereditary breast cancer: clinical, pathological and molecular characteristics.Immunophenotypic predictive profiling of BRCA1-associated breast cancer.Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort.DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.Tumor characteristics and prognosis in familial breast cancer.Immunoprofile from tissue microarrays to stratify familial breast cancer patientsVariants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families.MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours.Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families.Pathology of hereditary breast cancer.Triple-negative breast cancer: present challenges and new perspectives.Phenotype-genotype correlation in familial breast cancer.Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families.Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases.The Preventive Intervention of Hereditary Breast Cancer.Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.Pathology of hereditary breast cancer.Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population.Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.
P2860
Q31096420-2F7401EC-4D2C-4B98-8984-D09A1640473FQ34425230-5266F102-0C07-4F61-ABD9-F92CF355E7FCQ34467646-96F3FF90-6F87-4C24-8F8D-5850C7A033ABQ35050475-4CC3992C-00C7-4592-A026-1D3A18FDAEAEQ35835922-16A09D3E-26E8-4569-B49B-BF18F79436B8Q36207051-40C4686B-9DCE-4787-B459-CB5425812A11Q36413928-3AEF339C-4E0B-4C20-AAC7-0F21ECA85992Q36482312-38CF19F0-83E4-4265-B00B-EF94B4DE8923Q37322992-A83FE769-D2F6-44C7-BC5B-C0435DCC3C0BQ37324446-0B636996-9DE7-47AE-B957-817786DAC370Q37539804-F658507D-3C87-4619-82B2-6C0A4C3DA506Q37740949-A57B4DB0-4CDF-4308-AED0-AECBE96E35D5Q37764168-ECB0E419-7A58-4358-B3DC-25290E384751Q37852615-82D215FA-1FFE-47EE-ADFF-53DA5781ACEDQ42522379-65E702CE-C13D-44AF-876A-97B8D844365DQ45784223-87DFA5E0-E044-4825-AA02-FBD6CD4BF1B5Q46713406-3CF773D8-FC44-4F79-9ADA-B34C767DCA1EQ47559670-7E302A53-017D-492D-8176-CDB72C721CB7Q50485878-C2322D61-5AEA-417B-88D9-9483721D17C1Q53279057-8239B8FD-009E-4516-A503-6041A57C302FQ53310020-51BB9785-D9AE-432C-A541-6CE0D8E20DDDQ54415246-2D4BF488-2F14-4D44-A19B-0618C656C888Q54488788-A6406556-1A1D-481A-BF26-11A413095A24Q55110010-E6D817FD-00D0-429F-8815-AFF0162B41A5Q55191144-68A061C3-0972-4557-A460-48FF67356D06Q55711702-673097C6-9325-4C44-9DBB-3A10183A4FD3
P2860
Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Immunohistochemical classifica ...... terogeneity of BRCAX families.
@en
Immunohistochemical classifica ...... terogeneity of BRCAX families.
@nl
type
label
Immunohistochemical classifica ...... terogeneity of BRCAX families.
@en
Immunohistochemical classifica ...... terogeneity of BRCAX families.
@nl
prefLabel
Immunohistochemical classifica ...... terogeneity of BRCAX families.
@en
Immunohistochemical classifica ...... terogeneity of BRCAX families.
@nl
P2093
P2860
P50
P1433
P1476
Immunohistochemical classifica ...... terogeneity of BRCAX families.
@en
P2093
Enrique Lerma
Javier Benítez
José Palacios
Lorenzo Melchor
María F Paz
Miguel Urioste
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800969
P577
2007-09-21T00:00:00Z
P5875
P6179
1024189295